Hi, what are you looking for?
Jewish Business News
Search results for "Copaxone"
Business
Judge rules against Israeli pharma firm in its suit over alleged fraud by Mexican Espinosa brothers; Teva posts $5.7 billion 2Q revenue - less...
Health New Researches
Multiple sclerosis, one of the most devastating neurodegenerative diseases, affects some 2.5 million people worldwide and has no known cure. Researchers have long speculated...
Life science
Teva bribery: An investigation is being conducted in Israel regarding the same issues which led to a settlement with American justice authorities.
Business
Teva appointed Dr. Yitzhak Peterburg as Interim, succeeding Erez Vigodman. Dr. Sol J. Barer named Chairman of the Board
Life science
US Justice Department announced Thursday that Israeli Teva Pharmaceutical Industries will pay $519 million fine to settle charges concerning violations of the Foreign Corrupt Practices...
Mergers & Acquisitions
Teva will pay over $45 billion for the botox maker unit, report the "Wall Street Journal."
Business
As Israel’s biggest company Teva strives to get even bigger by swallowing up rival Mylan for more than $40 billion, further down the food...
Business
Last week Teva CEO, Erez Vigodman said, “If the Mylan Pharmaceuticals shareholders support the acquisition of Perrigo, Teva will abandon its bid for Mylan.”
Business
Teva Pharmaceutical Industries Ltd, an Israeli-based company, has acquired a 1.35 percent stake in Mylan through purchases on the open market, increasing pressure on...
Business
Teva CFO Eyal Desheh told Merrill Lynch that it could secure antitrust clearance for the takeover in 4-7 months.